Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
Mario Gennaro Mazza, Raffaella Zanardi, Mariagrazia Palladini, Patrizia Rovere‐Querini, Francesco Benedetti
Topics & Concepts
AntidepressantDepression (economics)Serotonin reuptake inhibitorMajor depressive disorderInternal medicineMedicineCoronavirus disease 2019 (COVID-19)PsychiatryMoodRating scalePsychologyDiseaseAnxietyMacroeconomicsEconomicsDevelopmental psychologyInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 and Mental HealthTryptophan and brain disorders